Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis
Stopped early · Phase 2 · Has a placebo group
Conditions studied: Noninfectious Uveitis
In brief
The primary objective of this study is to evaluate the efficacy of filgotinib versus placebo for the treatment of the signs and symptoms of noninfectious uveitis as measured by the percentage of participants failing treatment for active noninfectious uveitis by Week 24.
Key facts
- Study ID
- NCT03207815
- Run by
- Gilead Sciences
- People needed
- 74
- Starts
- 2017-07-26
- Expected to finish
- 2021-04-22
- Last updated by the study team
- 2022-01-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford Byers Eye Institute — Palo Alto, California, United States
- Colorado Retina Associates PC — Golden, Colorado, United States
- Northwestern Medical Group — Chicago, Illinois, United States
- Illinois Retina Associates — Oak Park, Illinois, United States
- Ophthalmic Consultants of Boston — Boston, Massachusetts, United States
- Associated Retinal Consultants PC — Royal Oak, Michigan, United States
- Metropolitan Eye Research and Surgery Institute — Palisades Park, New Jersey, United States
- Duke University Eye Center — Durham, North Carolina, United States
- Wake Forest Baptist Medical Center — Winston-Salem, North Carolina, United States
- Cleveland Clinic Foundation-Cole Eye Institute — Cleveland, Ohio, United States
- Oregon Health Science University-Casey Eye Institute — Portland, Oregon, United States
- Mid Atlantic Retina — Philadelphia, Pennsylvania, United States
- Texas Retina Associates - Fort Worth — Fort Worth, Texas, United States
- Foresight Studies, LLC — San Antonio, Texas, United States
- university of Wisconsin-Madison — Madison, Wisconsin, United States
- Lions Eye Institute — Nedlands, Western Australia, Australia
- Retina Consultants — Vancouver, Canada
- St. Franziskus Hospital — Münster, Germany
- Hadassah Medical Center — Jerusalem, Israel
- Auckland Eye — Remuera, New Zealand
- Royal Liverpool University Hospital — Liverpool, United Kingdom
- Moorfields Eye Hospital NHS Foundation Trust — London, United Kingdom
- Central Mancester Hospitals NHS Foundation Trust, Manchester Royal Eye Hospital — Manchester, United Kingdom
- Eye Research Group Oxford, Oxford Eye Hospital — Oxford, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.